Diethylphosphonoacetic Acid CAS 3095-95-2 Purity >99.5% (HPLC) Afatinib Dimaleate Intermediate Factory

Short Description:

Chemical Name: Diethylphosphonoacetic Acid

CAS: 3095-95-2

Purity: >99.5% (HPLC) 

Appearance: Colorless Liquid

Intermediate of Afatinib Dimaleate (CAS: 850140-73-7)

High Quality, Commercial Production

E-Mail: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

Description:

Chemical Properties:

Chemical Name Diethylphosphonoacetic Acid
Synonyms 2-(Diethoxyphosphoryl)acetic Acid; (Diethoxyphosphinyl)acetic Acid; Diethyl Carboxymethylphosphonate; NSC 272281
CAS Number 3095-95-2
CAT Number RF-PI2024
Stock Status In Stock, Production Capacity 30MT/Month
Molecular Formula (C2H5O)2P(O)CH2CO2H 
Molecular Weight 196.14
Boiling Point 150℃/0.05 mmHg (lit.)
Density  1.220 g/mL at 25℃ (lit.)
Refractive Index n20/D 1.445 (lit.)
Brand Ruifu Chemical

Specifications:

Item Specifications
Appearance Colorless Liquid
Identification (HPLC) The retention time of the main peak obtained from the sample is within 5% of the reference sample.
Purity / Analysis Method >99.5% (HPLC)
Infrared Spectrum Conforms to Structure
Proton NMR Spectrum Conforms to Structure
Moisture (K.F) <0.50%
Total Impurities <0.50%
Test Standard Enterprise Standard
Usage Intermediate of Afatinib Dimaleate (CAS: 850140-73-7)

Package & Storage:

Package: Fluorinated Bottle, 25kg/ Drum, or according to customer's requirement

Storage Condition: Store in sealed containers at cool and dry place; Protect from light and moisture

Advantages:

1

FAQ:

Application:

Diethylphosphonoacetic Acid (CAS: 3095-95-2), Acts as a nucleophile for nucleophilic addition reactions for synthesis of allene epoxides Reactant for: Stereoselectivity studies of the Staudinger reaction; Enantioselective formation of diols via epoxidation and hydration reactions; Horner-Wadsworth-Emmons reactions; Remote chelation controlled Ireland-Claisen rearrangement; Ugi-Dieckmann reactions for synthesis of tetramic acid derivatives; Used to make phosphonoester intermediates for intramolecular HEW reactions. Diethylphosphonoacetic Acid is an intermediate of Afatinib Dimaleate (CAS: 850140-73-7). Afatinib Dimaleate was approved by the U.S. Food and Drug Administration (FDA) in 2013 for the treatment of non-small cell lung cancer (NSCLC). Specifically, it was approved for patients presenting with metastatic NSCLC tumors which contain epidermal growth factor receptor (EGFR) exon deletions or exon 21 mutations. Afatinib Dimaleate is a covalent inhibitor of ErbB tyrosine kinases (tyk), which downregulates ErbB signaling by irreversible binding of EGFR tyk binding sites.

  • Write your message here and send it to us